1984•Clinical and Experimental DermatologyRequires access

Short course ketoconazole therapy in pityriasis versicolor

Rod J. Hay, G. MIDGELEY

Open publisher page 41 citations

Abstract

Treatment regimes for pityriasis versicolor consisting of 5, 15 or 25 days of ketoconazole (200 mg daily) were compared in a blind study. There were no differences in the cure or relapse rates with these treatment regimes. Overall cure rates 6 weeks after therapy ranged from 78% to 90%. Treatment with a daily 200 mg tablet of ketoconazole for 5 days can be used for most cases of pityriasis versicolor with longer periods of oral therapy being reserved for resistant cases. Short course ketoconazole will need to be compared against alternative topical forms of antifungal therapy.

About this research paper

What this paper is about

Treatment regimes for pityriasis versicolor consisting of 5, 15 or 25 days of ketoconazole (200 mg daily) were compared in a blind study. There were no differences in the cure or relapse rates with these treatment regimes. Overall cure rates 6 weeks after therapy ranged from 78% to 90%. Treatment with a daily 200 mg tablet of ketoconazole for 5 days can be used for most cases of pityriasis versicolor with longer periods of oral therapy being reserved for resistant cases. Short course ketoconazole will need to be compared against alternative topical forms of antifungal therapy.

Why it matters

OpenAlex reports 41 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Treatment regimes for pityriasis versicolor consisting of 5, 15 or 25 days of ketoconazole (200 mg daily) were compared in a blind study. There were no differences in the cure or relapse rates with these treatment regimes. Overall cure rates 6 weeks after therapy ranged from 78% to 90%. Treatment with a daily 200 mg tablet of ketoconazole for 5 days can be used for most cases of pityriasis versicolor with longer periods of oral therapy being reserved for resistant cases. Short course ketoconazole will need to be compared against alternative topical forms of antifungal therapy.

Key concepts: Pityriasis, Ketoconazole, Medicine, Antifungal, Dermatology, Mycosis, Tinea versicolor, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Short course ketoconazole therapy in pityriasis versicolor — Research Paper | ScholarLens